CELL INTELLIGENCE · 肿瘤细胞治疗研究

靶向 HER2 的 CAR-T 细胞在体外和体内均对胶质母细胞瘤表现出高效抗肿瘤活性

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo.

我们的研究表明，HER2 CAR-T 细胞是治疗 GBM 的一种新兴免疫疗法。

免疫治疗和靶向治疗联合化疗在老年 HER2 阳性胃食管结合部癌患者中的长期生存：一例病例报告

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction ca

HER2（3+）和PD-L1（<5%）免疫组化染色为阳性。